v3.26.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total Stockholder's Equity
Common Stock
Capital in Excess of Par Value
Cumulative Net Income
Accumulated OCI
Cumulative Distributions
Non-controlling Interests
Total
Balance at beginning of period at Dec. 31, 2024 $ 960,627 $ 455 $ 1,082,764 $ 1,725,435 $ 3,815 $ (1,851,842) $ 92,378 $ 1,053,005
Balance (in shares) at Dec. 31, 2024   45,511            
Equity activity                
Issuance of common stock 8,411 $ 2 8,409         8,411
Issuance of common stock (in shares)   238            
Issuance of restricted stock   $ 1 (1)          
Issuance of restricted stock (in shares)   114            
Common stock cash distributions (27,259)         (27,259)   (27,259)
Stock-based compensation expense 2,253   2,253         2,253
Net income 20,680     20,680     1,541 22,221
Vesting of performance-based stock units   $ 2 (2)          
Vesting of performance-based stock units (in shares)   163            
Fair market valuation adjustment for interest rate swap (910)       (910)     (910)
Cash paid for taxes in lieu of common shares (4,772) $ (1) (4,771)         (4,772)
Cash paid for taxes in lieu of common shares (in shares)   (138)            
Acquisitions of non-controlling interest 2,883   2,883       (4,033) (1,150)
Non-controlling interest distributions             (2,486) (2,486)
Other (11)   (11)         (11)
Balance at end of period at Mar. 31, 2025 961,902 $ 459 1,091,524 1,746,115 2,905 (1,879,101) 87,400 1,049,302
Balance (in shares) at Mar. 31, 2025   45,888            
Balance at beginning of period at Dec. 31, 2025 1,074,984 $ 485 1,189,846 1,843,407 482 (1,959,236) 87,400 1,162,384
Balance (in shares) at Dec. 31, 2025   48,482            
Equity activity                
Issuance of common stock 43,294 $ 11 43,283         43,294
Issuance of common stock (in shares)   1,146            
Issuance of restricted stock   $ 1 (1)          
Issuance of restricted stock (in shares)   130            
Common stock cash distributions (29,171)         (29,171)   (29,171)
Stock-based compensation expense 2,064   2,064         2,064
Net income 23,593     23,593     1,363 24,956
Vesting of performance-based stock units   $ 2 (2)          
Vesting of performance-based stock units (in shares)   171            
Fair market valuation adjustment for interest rate swap 1,074       1,074     1,074
Cash paid for taxes in lieu of common shares (5,875) $ (1) (5,874)         (5,875)
Cash paid for taxes in lieu of common shares (in shares)   (150)            
Non-controlling interest distributions             (15,688) (15,688)
Other (12)   (12)         (12)
Balance at end of period at Mar. 31, 2026 $ 1,109,951 $ 498 $ 1,229,304 $ 1,867,000 $ 1,556 $ (1,988,407) $ 73,075 $ 1,183,026
Balance (in shares) at Mar. 31, 2026   49,779